Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more?
Azari
N P
NP
Pietrini
P
P
D000328:Adult; D000544:Alzheimer Disease / Q000000981:diagnostic imaging / Q000378:metabolism; D001480:Basal Ganglia Diseases / Q000000981:diagnostic imaging* / Q000378:metabolism; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism; D006801:Humans; D006816:Huntington Disease / Q000000981:diagnostic imaging / Q000378:metabolism; D014055:Tomography, Emission-Computed
D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose; D005947:Glucose